Observational studyThe American journal of gastroenterology2016
The Real-World Effectiveness and Safety of Vedolizumab for Moderate-Severe Crohn's Disease: Results From the US VICTORY Consortium.
Parambir S Dulai et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
140 papers cite itlatest 60 shown
this paperpooled ittrialcites it